- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Tapentadol IR (CG5503)
Total 394 results
-
Pacira Pharmaceuticals, IncCompletedType 2 Diabetes Mellitus | Osteoarthritis of the KneeUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
PLx PharmaCompletedBioequivalenceUnited States
-
Johnson & Johnson Taiwan LtdTerminated
-
Pacira Pharmaceuticals, IncCompletedOsteoarthritis of the Hip | Osteoarthritis of the ShoulderUnited States
-
Pacira Pharmaceuticals, IncCompletedBilateral Knee OsteoarthritisUnited States
-
NeuroDerm Ltd.CompletedParkinson's DiseaseUnited States, Israel, Italy, Austria
-
Reckitt Benckiser Healthcare (UK) LimitedPremier Research Group plcRecruiting
-
CTI-1, LLCGlaxoSmithKline; CTI Clinical Trial and Consulting ServicesCompletedCongestive Heart FailureUnited States
-
Vallon Pharmaceuticals, Inc.Completed
-
Mario Negri Institute for Pharmacological ResearchCompletedNeuropathic Pain | Tumor | Cancer Pain | Breakthrough Cancer PainItaly
-
Pacira Pharmaceuticals, IncCompletedOsteoarthritis of the KneeUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Syneos HealthCompleted
-
Intec Pharma Ltd.UnknownParkinson's DiseaseUnited States, Spain, Italy, Israel, Poland, United Kingdom, Bulgaria, Germany, Slovakia, Ukraine
-
Astellas Scientific & Medical Affairs, Inc.CompletedUrologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urinary Bladder OveractiveUnited States, Canada
-
Impax Laboratories, LLCCompletedParkinson's DiseaseUnited States
-
Pacira Pharmaceuticals, IncCompletedOsteoarthritis of the KneeAustralia
-
Seoul National University Bundang HospitalChong Kun Dang Pharmaceutical Corp.UnknownHeart Failure With Reduced Ejection FractionKorea, Republic of
-
Chong Kun Dang PharmaceuticalUnknownEssential Hypertension | Congestive Heart Failure | Chronic Stable AnginaKorea, Republic of
-
Ludwig Institute for Cancer ResearchPfizer; Heidelberg Pharma AGTerminatedRenal Cell Carcinoma (RCC)Australia
-
AbbVie (prior sponsor, Abbott)Completed
-
Horizon Therapeutics Ireland DACCompleted
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
AstraZenecaCompletedPharmacokinetics | Bioequivalence | Healthy Japanese SubjectsUnited Kingdom
-
TakedaCompletedGout | Moderate Renal ImpairmentUnited States
-
AmgenCompletedHealthy VolunteersUnited States
-
TakedaCompleted
-
Boehringer IngelheimCompleted
-
AbbVie (prior sponsor, Abbott)Quintiles, Inc.CompletedAdvanced Parkinson's DiseaseUnited States, New Zealand
-
BayerCompletedSeasonal Allergic Rhinitis | Vasomotor Rhinitis
-
AbbVie (prior sponsor, Abbott)Quintiles, Inc.CompletedAdvanced Parkinson's DiseaseUnited States, Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
AstraZenecaCompletedHealthy Subjects | BioavailabilityGermany
-
H. Lundbeck A/SCompleted
-
Andrei IagaruNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSquamous Cell Carcinoma of the Head and Neck | Carcinoma of the Head and NeckUnited States
-
Nexgen Pharma, IncPharmaceutical Research Unit, JordanCompleted
-
Nexgen Pharma, IncCompleted
-
Terran Biosciences Australia Pty LtdRecruiting
-
Boehringer IngelheimCompleted
-
Janssen Research & Development, LLCCompletedSchizophreniaUnited States, Belgium, Taiwan, Spain, Israel, Malaysia, South Africa, Korea, Republic of, Slovakia, Croatia, Bulgaria
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands